N-(2-HYDROXYETHYL)-2-NITROBENZENESULFONAMIDE, 95.0%, 500mg

Methyl 5-bromo-2-(difluoromethoxy)benzoate, 95.0%, 100mg

1-(Naphthalen-1-yl)-1H-tetrazole, 98%, 250mg

Molecular Sieve (1.6-2.5mm bead size) 4A Pore Size, 100g

(2s)-3-(4-Hydroxyphenyl)-2-(prop-2-enamido)propanoic acid, 98%, 250mg

Hematoxyline, 95.0%, 5g

6-Phenyl-m-anisidine hydrochloride, 1g

2-(1-METHYL-1H-IMIDAZOL-4-YL)ETHAN-1-AMINE, 95.0%, 250mg

4-FLUORO-6-AZAINDOLE, 95.0%, 500mg

(4-Fluoropyridin-2-yl)methanamine dihydrochloride, 97%, 1g

Plan PLPH 10x/0.25 phase contrast objective

5-(4-Bromophenyl)-2H-pyrazol-3-ylamine, 97.0%, 100g

1-hydroxyl-1H-pyridine-2-thione, 250mg